Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity

Neoplasia

Volumn 12, Issue 3, 2010, Pages 254-263

  Schneider, Manuela ^a,b   Wortmann, Markus ^a   Mandal, Pankaj Kumar ^b   Arpornchayanon, Warangkana ^a,c   Jannasch, Katharina ^d   Alves, Frauke ^d   Strieth, Sebastian ^c   Conrad, Marcus ^b   Beck, Heike ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; BAICALEIN; BASIC FIBROBLAST GROWTH FACTOR; GLUTATHIONE PEROXIDASE; MATRIGEL; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TUMOR CELLS AND CELL LINES; TUMOR GROWTH; TUMOR SPHEROID; UPREGULATION; WILD TYPE;

EID: 77949621085     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.91782     Document Type: Article

References (36)

1. Ursini F, Maiorino M, Valente M, Ferri L, and Gregolin C (1982). Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta 710, 197-211.
2. Imai H, Narashima K, Arai M, Sakamoto H, Chiba N, and Nakagawa Y (1998). Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase. J Biol Chem 273, 1990-1997.
3. Hemler ME, Crawford CG, and Lands WE (1978). Lipoxygenation activity of purified prostaglandin-forming cyclooxygenase. Biochemistry 17, 1772-1779.
4. Lands WE (1985). Interactions of lipid hydroperoxides with eicosanoid biosynthesis. J Free Radic Biol Med 1, 97-101.
5. Fürstenberger G, Krieg P, Müller-Decker K, and Habenicht AJR (2006). What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119, 2247-2254.
6. Conrad M, Schneider M, Seiler A, and Bornkamm GW (2007). Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals. Biol Chem 388, 1019-1025.
7. Seiler A, Schneider M, Förster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, et al. (2008). Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8, 237-248.
8. Loscalzo J (2008). Membrane redox state and apoptosis: death by peroxide. Cell Metab 8, 182-183.
9. Shureiqi I and Lippman SM (2001). Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61, 6307-6312.
10. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, et al. (1999). Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20, 1985-1995.
11. Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, et al. (2003). Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63, 2256-2267.
12. Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y, and Shappell SB (2004). 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Hum Pathol 35, 840-849.
13. Subbarayan V, Xu X, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, et al. (2005). Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia 7, 280-293.
14. Tang DG, Bhatia B, Tang S, and Schneider-Broussard R (2007). 15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins Other Lipid Mediat 82, 135-146.
15. Hsi LC, Wilson L, Nixon J, and Eling TE (2001). 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. J Biol Chem 276, 34545-34552.
16. Eling TE and Glasgow WC (1994). Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Cancer Metastasis Rev 13, 397-410.
17. Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, and Sweeney CJ (2000). Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 21, 139-146.
18. Yoshinaga M, Buchanan FG, and DuBois RN (2004). 15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells. Prostaglandins Other Lipid Mediat 73, 111-122.
19. Kim J, Baek SJ, Bottone FG, Sali T, and Eling TE (2005). Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells. Mol Cancer Res 3, 511-517.
20. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, and Lippman SM (2000). 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92, 1136-1142.
21. Beck H, Semisch M, Culmsee C, Plesnila N, and Hatzopoulos AK (2008). Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am J Pathol 173, 77-92.
22. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F, et al. (2004). Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24, 9414-9423.
23. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, and Jain RK (1994). Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54, 4564-4568.
24. Missbach-Guentner J, Dullin C, Kimmina S, Zientkowska M, Domeyer-Missbach M, Malz C, Grabbe E, Stühmer W, and Alves F (2008). Morphologic changes of mammary carcinomas in mice over time as monitored by flat-panel detector volume computed tomography. Neoplasia 10, 663-673.
25. Jannasch K, Dullin C, Heinlein C, Krepulat F, Wegwitz F, Deppert W, and Alves F (2009). Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography. Int J Cancer 125, 62-70.
26. Kleinman HK and Martin GR (2005). Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15, 378-386.
27. Sen M, McHugh K, Hutzley J, Philips BJ, Dhir R, Parwani AV, and Kelavkar UP (2006). Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions. Prostaglandins Other Lipid Mediat 81, 1-13.
28. Deschamps JD, Kenyon VA, and Holman TR (2006). Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem 14, 4295-4301.
29. van Leyen K, Kim HY, Lee S, Jin G, Arai K, and Lo EH (2006). Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37, 3014-3018.
30. Lapchak PA, Maher P, Schubert D, and Zivin JA (2007). Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience 150, 585-591.
31. Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, and Honn KV (2007). Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 26, 503-524.
32. Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, and Badr KF (2001). Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22, 1765-1773.
33. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, and Funk CD (1999). Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 103, 1597-1604.
34. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kühn H, Guevara NV, and Chan L (1996). Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98, 2201-2208.
35. Harats D, Ben-Shushan D, Cohen H, Gonen A, Barshack I, Goldberg I, Greenberger S, Hodish I, Harari A, Varda-Bloom N, et al. (2005). Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Lett 229, 127-134.
36. Viita H, Markkanen J, Eriksson E, Nurminen M, Kinnunen K, Babu M, Heikura T, Turpeinen S, Laidinen S, Takalo T, et al. (2008). 15-Lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and down-regulation of VEGF receptor 2 expression. Circ Res 102, 177-184.